China SXT Pharmaceuticals, Inc. Announces Share Consolidation
China SXT Pharmaceuticals Announces 1-For-100 Reverse Stock Split, Effective Oct. 26
China SXT Pharmaceuticals Inc Announces Termination of Additional Purchase Right
Univest Securities, LLC Announces Closing of $12 Million Registered Direct Offering for its Client China SXT Pharmaceuticals Inc. (NASDAQ: SXTC)
China SXT Pharmaceuticals Announces $12 Million Registered Direct Offering With Significant Dilution Potential
China SXT Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering
China SXT Pharmaceuticals Commences ~$12M Offering Of 8M Class A Ordinary Shares At $1.50 Per Share
China SXT Pharmaceuticals Announces 1-For-80 Reverse Stock Split, Effective Aug. 10
Univest Securities, LLC Announces Closing of $9 Million Registered Direct Offering for its Client China SXT Pharmaceuticals Inc. (NASDAQ: SXTC)
China SXT Pharmaceuticals Inc. Announces $9 Million Registered Direct Offering
China SXT Pharmaceuticals Commences ~$9M Offering Of 4.5M Class Ordinary Shares At $3.20/Share
China SXT Pharmaceuticals Shares Surge Over 25% After Hours: Here's Why
China SXT Pharmaceuticals Files Prospectus To Offer Up To $100M Of Class A Ordinary Shares
China SXT Pharmaceuticals Sold 2M Shares For Gross Proceeds Of $760K On April 7, 2026
China SXT Pharmaceuticals, Inc. Announces Share Re-classification
China SXT Pharmaceuticals Announces Share Reclassification Effective March 24th; Ordinary Shares To Be Reclassified As Class A Ordinary Shares, Trade Under Symbol "SXTC"
Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.
